And $NVO calls FDA's interpretation of the deemed to be a license provision of the BPCIA "unconstitutional." ...50% of Novo's marketed and pipeline products will be impacted - that should be be an engaging fight to watch in 2019/2020 https://t.co/nNNax52zNG
Three Things #BPCI Advanced Participants Should Be Doing Now: https://t.co/OPWyRq5MrC via @PremierHA
